98%
921
2 minutes
20
Introduction: The aim of the present study was to examine the relationship between post-extraction pain and acute pulpitis in third molars.
Methods: This study was a randomised controlled trial. Sixty patients requiring removal of a single maxillary third molar with acute pulpitis were included and randomly divided into two groups: group A (n = 30); and group B (n = 30). In group A, third molars were directly extracted, and group B received endodontic therapy (pulp chamber opening and drainage) and underwent extraction 24 hours later, aiming to eliminate the acute inflammation. Another 30 patients requiring removal of a single maxillary third molar and with the same inclusion criteria but without caries or acute pulpitis were recruited into group C, in which the maxillary third molars were also directly extracted. The level of postoperative pain reported each day among the three groups was statistically evaluated.
Results: On the first, second and third days after surgery, there was a statistically significant difference between group A and group B and between group A and group C, but there was no statistically significant difference between group B and group C.
Conclusion: The results of the present study indicate that there is more pain when third molars with acute pulpitis are directly removed compared with the pain level of the removal of third molars without acute pulpitis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376631 | PMC |
http://dx.doi.org/10.1111/idj.12249 | DOI Listing |
J Conserv Dent Endod
August 2025
Department of Conservative Dentistry and Endodontics, AB Shetty Memorial Institute of Dental Sciences, Nitte (Deemed to be University), Mangalore, Karnataka, India.
Context: Antimicrobial resistance represents a global health crisis, with the oral microbiome serving as a significant reservoir for resistance genes. Despite guidelines discouraging antibiotic use for irreversible pulpitis, empirical prescription remains common in endodontic practice. This study aimed to evaluate the prevalence of β-lactam and tetracycline resistance genes in acute and chronic irreversible pulpitis.
View Article and Find Full Text PDFMater Today Bio
October 2025
Department of Stomatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Continuous decompression and drainage are a vital surgical strategy for managing severe tissue infections. In vital pulp therapy (VPT) for irreversible pulpitis, there is a clinical demand for advanced biomaterials capable of effectively sealing the pulp cavity, alleviating pulpal hypertension, preventing bacterial infiltration, and resolving acute pulp inflammation in bacteria-rich environments. In this study, we developed a polydopamine@zinc oxide nanoparticle (ZnO-NP)-coated polytetrafluoroethylene (PTFE) membrane with tunable Zn content ranging from 2.
View Article and Find Full Text PDFEur Endod J
July 2025
Department of Endodontics, Suez Canal University, Faculty of Dentistry, Ismailia, Egypt.
Objectives The trial was conducted to assess the impact of passive ultrasonic irrigation, XP endo finisher, AF max file, and manual dynamic agitation on postoperative pain and analgesic consumption at 6 h., 12 h., 24 h.
View Article and Find Full Text PDFInt Dent J
August 2025
Department of Oral Emergency, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, 100081, PR China. Electronic ad
Introduction And Aims: Making precise diagnoses of patients with dental pain is challenging. Thus, a screening system that can help accurately stratify patients depending on the severity of their condition is required. In this study, we compared the characteristics of dental pain in patients with different conditions using a Short-Form McGill Pain Questionnaire (SF-MPQ).
View Article and Find Full Text PDFJ Clin Med
June 2025
Department of Temporomandibular Disorders, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland.
Cannabidiol (CBD), a non-intoxicating phytocannabinoid, has garnered interest as a potential therapeutic agent for managing pain and inflammation associated with upper-quarter disorders, including temporomandibular disorders (TMDs), orofacial pain, myofascial dysfunction, and postoperative dental pain. : This systematic review critically evaluated clinical, preclinical, and mechanistic studies on the efficacy and safety of CBD in the management of such conditions. A total of 10 studies, comprising randomized clinical trials and animal models, met the inclusion criteria and were assessed for methodological quality and risk of bias.
View Article and Find Full Text PDF